Peru DIGEMID Medical Device Registration Guide: Classification, Process & Fees

Peru's Growing Medical Device Market

Peru is an increasingly important market for medical devices in Latin America. The country's medical device market is valued at approximately $632.8 million in 2026, with projections reaching $671.2 million by 2027, driven by growing healthcare expenditure, expanding access to modern medical technologies, and a population exceeding 34 million.

Under the U.S.-Peru Trade Promotion Agreement (PTPA), medical devices and pharmaceuticals from the United States enter Peru duty-free, making it an attractive market for U.S. manufacturers. However, all medical devices must be registered with the national regulatory authority before they can be commercially distributed.

Medical device regulation in Peru is administered by DIGEMID (Dirección General de Medicamentos, Insumos y Drogas) — the General Directorate of Medicines, Supplies and Drugs — operating under the Ministry of Health.

This guide provides a comprehensive overview of the registration process, classification system, documentation requirements, fees, timelines, and practical strategies for successfully entering the Peruvian medical device market.

The Regulatory Authority: DIGEMID

DIGEMID is a technical regulatory institution established by Legislative Decree No. 584 of April 18, 1990. Its primary responsibilities include:

• Sanitary registration of medical devices and IVDs
• Quality control and surveillance of health products
• Authorization and oversight of pharmaceutical establishments
• Post-market surveillance and adverse event reporting
• Import and export control for health products

DIGEMID operates the VUCE (Ventanilla Única de Comercio Exterior) electronic system for regulatory submissions and communications. This single-window platform streamlines interactions between the regulator and manufacturers.

Legal Framework

Peru's medical device regulatory framework is built on several key pieces of legislation:

Regulation	Scope
Law No. 29459	Law of Pharmaceuticals, Medical Devices, and Health Products — the primary governing legislation
Supreme Decree Nº 016-2013-SA	Regulation for Registration, Control and Health Surveillance of Medical Devices
Supreme Decree Nº 001-2012-SA	Medical device classification requirements
Supreme Decree Nº 003-2020-SA	Amendments to registration and control procedures
Medical Device Classification List PE-006	Detailed classification rules for medical devices

The classification system and registration procedures are aligned with IMDRF (International Medical Device Regulators Forum) guidelines and are broadly similar to the EU MDR and FDA classification frameworks.

Device Classification

Peru uses a four-class risk-based classification system that follows IMDRF principles:

Class	Risk Level	Review Timeline	Examples
Class I	Low risk	60 days	Bandages, surgical tape, manual wheelchairs, non-powered patient aids
Class II	Moderate risk	90 days	Condoms, hypodermic needles, contact lenses, dental cements, powered wheelchairs
Class III	High risk	120 days	Orthopedic implants, ventilators, surgical lasers, IVD test kits
Class IV	Critical risk	120 days	Heart valves, stents, implantable defibrillators, IVD reagents for blood screening

Classification is determined based on:

• Intended use — what the device is designed to do
• Duration of body contact — transient, short-term, or long-term
• Degree of invasiveness — non-invasive, invasive through body orifices, surgically invasive, or implantable
• Potential consequences of failure — the severity of harm if the device malfunctions

The classification rules are derived from GHTF/IMDRF guidance and closely mirror the European framework. Devices previously classified in the EU or US under a given risk class will typically receive the same classification in Peru.

Medical Device Definition in Peru

Under Law 29459, a medical device includes any instrument, equipment, implement, reagent, calibrator, or software manufactured for use in humans, intended for one or more of the following purposes:

• Diagnosis, prevention, monitoring, treatment, or alleviation of disease
• Diagnosis, monitoring, treatment, or alleviation of injury or handicap
• Investigation, replacement, or modification of anatomy or a physiological process
• Control of conception
• Disinfection of medical devices

This definition does not achieve its primary intended action by pharmacological, immunological, or metabolic means, but may be assisted in its function by such means.

Registration Dossier Requirements by Class

The documentation package required varies significantly by classification. Here is what DIGEMID requires for each class:

Requirement	Class I	Class II	Class III	Class IV
Application form	Required	Required	Required	Required
Certificate of Free Sale (CFS/CFG)	Required	Required	Required	Required
QMS certificate (ISO 13485/GMP)	Required	Required	Required	Required
Technical report	Required	Required	Required	Required
Instructions for Use (IFU)	Required	Required	Required	Required
Quality standards evidence (FDA/CE)	—	Required	Required	Required
Risk analysis	—	Required	Required	Required
Clinical evaluation report	—	—	Required	Required
Biological safety data	—	—	Required	Required
Post-market surveillance plan	—	—	Required	Required
List of countries where device is marketed	—	—	—	Required
Technical and analytical studies	Required	Required	Required	Required
Disposal methods (where applicable)	Required	Required	Required	Required
Draft package labeling	Required	Required	Required	Required

Certificate of Free Sale

DIGEMID recognizes CFS from specific countries. Recognized countries include:

• United States (FDA)
• European Union member states (France, Netherlands, Germany, Spain, Italy, Belgium, Portugal, Ireland, Denmark, Sweden, Norway)
• United Kingdom (MHRA)
• Canada (Health Canada)
• Japan (PMDA)
• Australia (TGA)
• South Korea (MFDS)
• Switzerland

If your device does not have a CFS from a recognized country, additional inspections may be required, which can significantly extend the registration timeline.

The Registration Process: Step by Step

Step 1: Appoint a Peru Registration Holder (PRH)

Foreign manufacturers without a legal entity in Peru must appoint a Peru Registration Holder (PRH). The PRH is your in-country representative and liaison with DIGEMID.

The PRH is responsible for:

• Holding the sanitary registration
• Submitting the registration application
• Communicating with DIGEMID
• Managing import documentation
• Handling post-market obligations

Choosing the right PRH is critical. The PRH legally controls the registration. If you later want to switch to a different distributor or representative, you must transfer the registration. Negotiate clear terms upfront for ownership, transfer rights, and termination conditions.

Step 2: Register Your Company via VUCE

The PRH (or your local entity) must register in the VUCE (Ventanilla Única de Comercio Exterior) electronic system. VUCE is an integrated electronic platform that facilitates regulatory communications and submissions.

Registration steps:

1. Access the VUCE portal
2. Create a user account
3. Identify as a company or natural person
4. Register pharmaceutical establishment details
5. Obtain system credentials

Step 3: Classify Your Device

Determine the correct risk classification using the Medical Device Classification List PE-006. The classification drives documentation requirements, review timeline, and fees.

If classification is uncertain, you can submit a classification inquiry through VUCE before proceeding with the full registration application.

Step 4: Compile the Registration Dossier

Prepare the full documentation package as specified for your device's classification class. All labeling and instructions for use must be in Spanish.

Key documents to prepare:

• Free Sale Certificate from a recognized country, legalized and translated
• ISO 13485 certificate or equivalent GMP documentation
• Technical report describing the device, its intended use, design, and performance
• Risk analysis per ISO 14971 (Class II and above)
• Clinical evaluation (Class III and IV)
• Spanish labeling and IFU

Step 5: Submit via VUCE

Create a registration request (SUCE — Solicitud Única de Comercio Exterior) through the VUCE system:

1. Create a new request in VUCE
2. Select the appropriate regulatory procedure
3. Upload all required documents
4. Pay the registration fee
5. Submit the application

Step 6: DIGEMID Review

DIGEMID's Directorate of Sanitary Authorizations reviews the submission. The review process includes:

• Administrative review — verifies completeness of the application and documentation
• Technical review — evaluates the technical file, safety data, and compliance with applicable standards
• Additional queries — DIGEMID may request additional information or clarifications through VUCE

Step 7: Registration Certificate Issued

Upon approval, DIGEMID issues a Directorial Resolution of Sanitary Registration (Resolución Directoral de Registro Sanitario). This is the marketing authorization that permits the device to be imported and sold in Peru.

The registration is valid for 5 years and must be renewed before expiry to maintain market access.

Registration Timelines

DIGEMID has established official review timelines:

Device Class	Official Timeline	Practical Timeline
Class I	60 days	3–4 months
Class II	90 days	4–6 months
Class III	120 days	5–8 months
Class IV	120 days	6–8 months

The practical timeline is typically longer than the official timeline due to:

• Administrative processing time
• Requests for additional information
• Translation and document preparation delays
• DIGEMID workload and resource constraints

Plan for the practical timeline when developing your market entry schedule.

Registration Fees

DIGEMID registration fees are relatively affordable compared to other LATAM markets:

Device Class	Fee (Approximate)
Class I	~$400 USD
Class II	~$460 USD
Class III	~$510 USD
Class IV	~$580 USD

Additional costs to budget for:

Cost Item	Estimated Range
Local representative/PRH fees	$2,000–$5,000/year
Document translation (Spanish)	$500–$2,000
Legalization of CFS	$200–$500
Regulatory consulting	$5,000–$15,000 (if outsourced)
Import dossier preparation	$500–$1,000 per shipment

Import Procedures

Once the device is registered, the PRH or importer must prepare an import dossier for customs clearance. The import dossier must include:

• Certificate of Analysis from the manufacturer for each batch
• Updated Sanitary Registration Directorial Resolution
• Commercial invoice
• Packing list
• VUCE resolution document (issued together with the registration resolution)

Under the PTPA, U.S.-origin medical devices enter Peru duty-free. The importer must present a U.S. certificate of origin to claim duty-free status.

Special Requirements

• Radioanalysis devices — must receive additional authorization from the Peruvian Nuclear Regulatory Authority
• Cold chain products — must comply with cold chain logistics requirements
• Pharmaceutical establishment registration — the importing entity must have a registered drugstore or warehouse in Peru, technically directed by a qualified Pharmaceutical Chemist

Quality Management System Requirements

DIGEMID requires a robust Quality Management System aligned with ISO 13485 for all device classes. The QMS should cover:

• Design and development controls
• Production and process controls
• Document and record management
• Corrective and preventive action (CAPA)
• Supplier management
• Complaint handling and adverse event reporting
• Internal audits and management review

For Class III and IV devices, evidence of a functioning QMS is scrutinized more rigorously during the technical review.

Post-Market Obligations

Adverse Event Reporting

Peru requires reporting of significant adverse events to DIGEMID. The PRH is responsible for:

• Submitting adverse event reports within defined timeframes
• Notifying DIGEMID of field safety corrective actions
• Maintaining records of all complaints and adverse events

Market Surveillance

DIGEMID conducts post-market surveillance activities including:

• Review of periodic safety update reports (for Class III/IV)
• Inspection of registered establishments
• Random product quality testing
• Review of labeling and promotional materials

Registration Renewal

Registrations must be renewed every 5 years. The renewal application should be submitted well before the expiry date to avoid any gap in market authorization. The renewal process requires:

• Updated technical documentation
• Current QMS certificate
• Summary of post-market surveillance data
• Updated labeling (if changed)
• Renewal fee payment

License Transfer

Registration transfers are possible. The application must be performed by the current holder of the registration certificate by submitting a document called Ownership Assignment (Cesión de Derechos). This is relevant when:

• Switching local representatives or distributors
• Company acquisitions or mergers
• Rebranding or corporate restructuring

Plan for transfer provisions in your PRH agreement to avoid being locked into an unfavorable relationship.

Peru vs. Other LATAM Markets

Factor	Peru (DIGEMID)	Brazil (ANVISA)	Chile (ISP)	Colombia (INVIMA)
Classification	Class I–IV	Class I–IV	Class I–IV	Class I–IV
Timeline (Class II)	4–6 months	6–12 months	6 months	4–8 months
Registration validity	5 years	10 years	Indefinite	10 years
Local representative	Required (PRH)	Required (BRH)	Required	Required
Language	Spanish	Portuguese	Spanish	Spanish
ISO 13485 required	Required	Required (BGMP)	Recommended	Required
Gov fees (Class II)	~$460	~$1,000–$6,000	~$200	~$500–$2,000
U.S. FTA	Yes (PTPA)	No	Yes	No
Electronic submission	VUCE	Not yet	GICONA	Not yet

Strategies for Faster Market Access

1. Use a CFS from a Recognized Country

A Certificate of Free Sale from the US (FDA), EU, UK, Canada, Japan, or Australia streamlines the process significantly. Without a recognized CFS, DIGEMID may require additional inspections, adding months to the timeline.

2. Prepare Complete Documentation Upfront

The most common cause of delays is incomplete documentation. Ensure every required document is prepared, translated, and legalized before submission. Address every item in the class-specific checklist.

3. Choose an Experienced PRH

Your PRH's familiarity with DIGEMID processes directly affects your timeline. An experienced PRH knows how to navigate queries, format submissions correctly, and maintain productive communication with the regulator.

4. Leverage Existing Approvals

DIGEMID recognizes devices that already have FDA clearance or CE marking. Include evidence of these approvals in your submission — it demonstrates that the device has already undergone rigorous regulatory review and can accelerate the technical assessment.

5. Submit Multiple Products Concurrently

If you have a product family, investigate whether DIGEMID allows grouped submissions. Registering multiple similar devices in one application can be more efficient than sequential registrations.

6. Engage Early with VUCE

Register in the VUCE system before you are ready to submit. Familiarity with the platform and established credentials prevent delays at the submission stage.

Common Mistakes to Avoid

1. Choosing the wrong PRH — Your PRH controls your registration. If you switch distributors later, you need to transfer the registration. Choose a reliable, independent PRH and negotiate clear transfer provisions.

2. Incomplete CFS documentation — The CFS must be from a recognized country and must be properly legalized (apostilled) and translated into Spanish. Failing to do this correctly causes immediate rejection.

3. Underestimating translation requirements — All labeling, IFUs, and key documents must be in Spanish. Poor or incomplete translations lead to queries and delays.

4. Not planning for practical timelines — Official timelines (60–120 days) are best-case scenarios. Plan for 4–8 months to avoid supply chain disruptions.

5. Ignoring post-market obligations — Adverse event reporting and registration renewal are ongoing responsibilities. Non-compliance can result in registration suspension.

6. Not budgeting for import logistics — Import dossiers, batch-specific certificates of analysis, and customs clearance add time and cost beyond the registration itself.

7. Submitting without checking classification — Misclassification leads to wrong documentation requirements and review pathway. Verify your classification using PE-006 before preparing the dossier.

Practical Checklist for Peru Market Entry

• Classify your device (Class I–IV) using PE-006
• Appoint a Peru Registration Holder (PRH)
• Register your company/entity in the VUCE system
• Obtain CFS from a recognized country (FDA, CE, etc.)
• Legalize and translate CFS into Spanish
• Prepare ISO 13485 / GMP certificate
• Compile technical report and risk analysis
• Prepare clinical evaluation (Class III/IV)
• Translate all labeling and IFU into Spanish
• Submit registration application via VUCE
• Pay registration fee
• Respond to any DIGEMID queries
• Receive Directorial Resolution of Sanitary Registration
• Set up import procedures and batch documentation
• Establish adverse event reporting processes
• Calendar registration renewal (5-year deadline)

Frequently Asked Questions

How long does DIGEMID registration take?

Officially, 60 days for Class I, 90 days for Class II, and 120 days for Class III/IV. In practice, expect 4–8 months depending on device complexity and application completeness.

Does Peru accept FDA clearance or CE marking?

Yes. While FDA clearance or CE marking does not replace DIGEMID registration, it is recognized as supporting evidence and can accelerate the technical review. You still need to submit a full registration application.

Is a local representative mandatory?

Yes. Foreign manufacturers must appoint a Peru Registration Holder (PRH) who is legally established in Peru. The PRH holds the registration and serves as the liaison with DIGEMID.

What language must documents be in?

All labeling, instructions for use, and product descriptions must be in Spanish. Technical documentation can be in English, but DIGEMID's preference is for Spanish-language submissions or Spanish summaries of key documents.

How much does registration cost?

Government fees range from approximately $400 (Class I) to $580 (Class IV). Total costs including PRH fees, translation, legalization, and consulting typically range from $8,000 to $25,000 depending on device complexity.

Does registration expire?

Yes. DIGEMID registrations are valid for 5 years and must be renewed before expiry. Plan your renewal application at least 6 months before the expiry date.

Can I transfer my registration to a new PRH?

Yes. Registration transfers are possible through a formal Ownership Assignment (Cesión de Derechos) process. The current holder must initiate the transfer. Include transfer provisions in your PRH agreement.

Are IVDs regulated separately?

IVDs are regulated under the same legal framework (Law 29459) but may have additional documentation requirements. IVD reagents and test kits are typically classified as Class II–IV depending on the intended use and risk.

Do I need ISO 13485 certification?

ISO 13485 is effectively required. While the regulation does not explicitly mandate ISO 13485 for all classes, a QMS certificate is listed as a required document for all classes. ISO 13485 from a recognized certification body is the most straightforward way to satisfy this requirement.

Does Peru have a fast-track pathway?

Peru does not have a formal fast-track pathway comparable to Mexico's COFEPRIS 30-day program. However, devices with existing FDA/CE approvals may experience faster technical review. Complete, well-prepared submissions also tend to move through the process more quickly.